For many people living with multiple sclerosis (MS), walking can become one of the most challenging daily tasks. As many as 3 in 4 people with MS have gait issues caused by factors like loss of muscle ...
Add Yahoo as a preferred source to see more of our stories on Google. At-home neurostimulation devices claim to lessen the symptoms of anxiety and chronic pain (Pulsetto) For most, the idea that you ...
Credit: Neurovalens. Modius Sleep is an electrical vestibular nerve stimulator that sends signals to a neural pathway that connects to the hypothalamus. Modius Sleep lowered Insomnia Severity Index by ...
HOUSTON, TEXAS, March 14, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that it has commenced sales of its second generation ...
HOUSTON, TX, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced ...
Shares of Nexalin Technology nearly doubled after the company said its second-generation Sync neurostimulation device can improve cognitive performance and enhance brain network connectivity in ...
OpenMind consortium accelerates creation of neurostimulation devices to sense, record brain activity
University researchers — along with teams at the University of California, San Francisco, Mayo Clinic and Oxford — have come together to establish the OpenMind neural communications consortium, a ...
Nexalin Technology, Inc. is inviting investors to join a webinar on January 23, 2025, at 4:15 p.m. ET, hosted by RedChip Companies. During the event, CEO Mark White will discuss the company's ...
The US Food and Drug Administration (FDA) has approved Abbott Laboratories' Proclaim XR neurostimulation system for chronic pain patients. The device has a battery life of up to 10 years, the company ...
HOUSTON, TX, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today ...
The MarketWatch News Department was not involved in the creation of this content. COSTA MESA, Calif., Oct. 21, 2025 /PRNewswire/ -- Amid record-high drug overdose rates and no FDA-approved medications ...
Would you try an electromagnetic headset that claims to ‘reset the vagus nerve’? Emilie Lavinia investigates the world of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results